Category: CovidienSyndicate content

TriVascular Tech recall of stent grafts may drag down full-year revenues | Medtech Wall Street news for the week of September 22, 2014

September 25, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: TriVascular Tech's stent graft recall could hurt the bottom line; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules; Baxano puts itself on the auction block; Philips to carve out lighting biz, merger healthcare & consumer units

TriVascular Tech's stent graft recall could hurt the bottom line

September 19, 2014 by Arezu Sarvestani

TriVascular Tech's stent graft recall could hurt the bottom line

New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy

September 24, 2014 by Brad Perriello

New U.S. Treasury rules on inversion deals are unlikely to scuttle Medtronic's pending $43 billion merger with Covidien, analysts say, but are likely to make it more complicated and expensive.

New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy

Exec at MDT explains how COV gained $43B payout | The week in medtech M&A

September 24, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together; Medtronic and Covidien prepare 1st Integration Summit; FTC approves Cerner's $1.3B Siemens health IT buy; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules

Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together

September 17, 2014 by Brian Johnson

Medtronic, Covidien slide on new U.S. inversion rules

September 23, 2014 by Brad Perriello

New rules on inversion mergers announced yesterday by the U.S. Treasury Dept. send shares of Medtronic and Covidien down as questions swirl about the impact ion their pending $43 billion merger.

Medtronic, Covidien slide on new U.S. inversion rules

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic and Covidien prepare 1st Integration Summit

September 18, 2014 by Arezu Sarvestani

Merging medtech titans Medtronic and Covidien are preparing to host the 1st of 4 Integration Summits, scheduled later this month.

Medtronic and Covidien prepare 1st Integration Summit

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together

September 17, 2014 by Brian Johnson

A senior executive at Medtronic, vice president of corporate development Chris Cleary, explains how Covidien played "scrappy" upstart all the way to a $43 billion payout.

Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together

Neurovascular: Covidien begins enrollment in 2 new trials

September 15, 2014 by Arezu Sarvestani

Covidien begins enrolling patients in clinical trials for its Pipeline embolization system as well as all its endovascular stroke devices.

Covidien begins enrollment for 2 new trials

Covidien (NYSE:COV) announced today that it enrolled the 1st patients in a pair of clinical trials evaluating the company's neurovascular technologies.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp